Cloning by somatic cell nuclear transfer (SCNT) circumvents processes that normally function during gametogenesis to prepare the gamete genomes to support development of new progeny following fertilization. One such process is enhanced maintenance of genetic integrity in germ cells, such that germ cells typically carry fewer spontaneously acquired mutations than somatic cells in the same individual. Thus, embryos produced from somatic cells by SCNT could directly inherit more mutations than naturally conceived embryos. Alternatively, they could inherit epigenetic programming that predisposes more rapid accumulation of de novo mutations during development. We used a transgenic mouse system to test these possibilities by producing cloned midgestation mouse fetuses from three different donor somatic cell types carrying significantly different initial frequencies of spontaneous mutations. We found that on an individual locus basis, mutations acquired spontaneously in a population of donor somatic cells are not likely to be propagated to cloned embryos by SCNT. In addition, we found that the rate of accumulation of spontaneous mutations was similar in fetuses produced by either natural conception or cloning, indicating that cloned fetuses do not acquire mutations more rapidly than naturally conceived fetuses. These results represent the first direct demonstration that the process of cloning by SCNT does not lead to an increase in the frequency of point mutations. These results also demonstrate that epigenetic mechanisms normally contribute to the regulation of genetic integrity in a tissue-specific manner, and that these mechanisms are subject to reprogramming during cloning. epigenetic reprogramming ͉ mutagenesis
epigenetic reprogramming ͉ mutagenesis C loning by the process of somatic cell nuclear transfer (SCNT) has been achieved in a variety of mammalian species and has potential applications for human health (1, 2) , improvement of agricultural species (3), protection of exotic or endangered species (4), propagation of companion animals (5) , and advancement of basic biological research (6, 7) . Numerous studies have been conducted on the status of epigenetic programming in cloned embryos or offspring, and defects in this programming have been associated with certain phenotypic defects seen in some cloned embryos or offspring (8, 9) . However, other than analyses of karyotypes (10) , few if any studies have been performed on the status of genetic integrity in cloned offspring, particularly at the level of point mutations. Thus, although concerns about potentially higher mutation frequencies in cloned offspring have been raised in the past (11) , the safety and efficacy of cloning from the perspective of maintenance of genetic integrity have not been well investigated to date.
Previous studies have shown that, at the level of spontaneous point mutations, genetic integrity is differentially maintained in a tissue-specific manner in mammals (12, 13) . In particular, spermatogenic cells accumulate spontaneous mutations to a significantly lower extent than somatic cells in males (14) . This implies the intriguing concept that genetic integrity is regulated, at least in part, by epigenetic mechanisms that appear to function more stringently in germ cells than in somatic cells. This is perhaps not surprising given that germ cells normally fulfill the unique function of contributing genetic information to the next generation. Thus, maintenance of genetic integrity appears to be subject to more stringent natural selection in germ cells than in somatic cells, and this presumably contributes to the ongoing fitness of the species.
However, because cloning by SCNT circumvents gametogenesis and the involvement of germ cell genomes (15, 16) , two key questions are raised regarding the status of genetic integrity in cloned embryos or offspring produced by SCNT-1) will embryos cloned from somatic cells inherit more point mutations than are normally transmitted to naturally conceived embryos derived from germ cells, and 2) will cloned fetuses produced by SCNT accumulate spontaneous mutations more rapidly than naturally conceived fetuses due to inheritance of less stringent epigenetic regulation of genetic integrity?
To address these questions, we used mice transgenic for a lambda shuttle vector carrying the lacI gene encoding the lac operon repressor, which facilitates the use of a chromogenic screen to determine the frequency of spontaneous point mutations (17) . We generated cloned embryos from three different donor somatic cell types carrying significantly different frequencies of point mutations and determined the frequency of spontaneous point mutations in midgestation fetuses produced by cloning from each donor cell type. We also compared the rate of accumulation of mutations in cloned fetuses with that in naturally conceived fetuses. Finally, we determined the spectrum of point mutations detected in the transgene recovered from each donor cell population and from corresponding cloned fetuses derived from each.
Results
We previously demonstrated that viable mouse fetuses produced by various assisted reproductive technologies (ARTs), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and round spermatid injection (ROSI), do not accrue more spontaneous mutations than naturally conceived and gestated fetuses (18) . This demonstrated that neither manipulation of oocytes in vitro, injection of genetic material into oocytes, preimplantation development of embryos in culture, nor transfer of cultured embryos into surrogate dams represent mutagenic events.
To examine the specific effects of generating embryos from donor somatic cell nuclei by cloning, we initially characterized the frequency of spontaneous point mutations in three different somatic cell types commonly used as donors for SCNT-fetal brain cells, adult cumulus cells, and adult skin cells. Frequencies of spontaneous point mutations detected in the lacI transgene recovered from each of these cell types were 1.01 ϫ 10 Ϫ5 , 2.54 ϫ 10 Ϫ5 , and 4.04 ϫ 10 Ϫ5 , respectively ( Fig. 1 , supporting information (SI) Table S1). These were significantly different from one another and, in the case of adult cumulus cells and adult skin cells, significantly higher than the frequency of spontaneous point mutations found in mature spermatozoa (0.78 ϫ 10 Ϫ5 ) (14) (note that data for frequencies of spontaneous point mutations in mature oocytes are not available).
We next examined the frequency of spontaneous point mutations in cloned, midgestation-stage fetuses produced from each donor somatic cell type. Unlike the significantly different frequencies of mutations that distinguished the three donor cell populations, fetuses cloned from each of these cell types possessed statistically similar frequencies of mutations (0.99-1.03 ϫ 10 Ϫ5 ). In addition, those cloned from adult somatic cell types (cumulus or skin cells) showed mutation frequencies that were significantly lower than the frequencies in each corresponding donor cell population (Fig. 1, Table S1 ). Indeed, the frequencies of mutations detected in fetuses cloned from all three donor cell types were similar to those observed in midgestation fetuses produced by natural conception and gestation or natural conception followed by preimplantation culture and embryo transfer (Fig. 1, Table S1 ), indicating that the rate of accumulation of de novo mutations during the first half of gestation was similar in all cases.
Despite the differences in frequencies of point mutations in the three donor cell populations, the spectrum of mutations in each were similar to one another (Fig. 2, Table S2 ), suggesting similar sources of the spontaneous mutations detected in each case. The spectra of point mutations found in cloned fetuses were also similar to those observed in the corresponding donor cell types and to those found in naturally conceived fetuses, with the exception of a slightly, but not significantly, higher frequency of insertions or deletions in fetuses cloned from adult cumulus or adult skin cells relative to those observed in naturally conceived fetuses (Fig. 2 , Table S2 ). C-to-T transitions were the predominant mutation in all cases, and appear to reflect the ubiquitously methylated state of the transgene in various tissues of transgenic mice (18, 19) . A detailed description of each mutation detected is presented in Table S3 .
Discussion
The results from this study indicate that neither the process of SCNT itself, nor the use of donor somatic cell nuclei, lead to an increase in the frequency of spontaneous mutations in cloned offspring. In addition, the rate of acquisition of spontaneous mutations in fetuses produced by SCNT appears to be similar to that following natural conception, at least during the first half of development. This represents the first report, to our knowledge, of a prospective, controlled study of the occurrence of spontaneous point mutations in cloned offspring, and therefore the first report suggesting that the process of cloning is safe with respect to maintenance of genetic integrity.
We used a transgenic system to assess the frequencies of point mutations in midgestation fetuses produced by natural conception or cloning. This was compelled by the relatively rare occurrence of spontaneous point mutations and the fact that mutations in this transgene can be conveniently and sensitively detected using a chromogenic screen. However, this raises a question as to whether the occurrence of mutations in this transgene is representative of that in endogenous genes in the murine genome. Effects imposed by the surrounding genomic context of a gene, or tissue-specific differences in expression activity and associated differences in chromatin structure could certainly influence the susceptibility of any single locus, be it a transgene or an endogenous gene, to mutagenic effects. However, the lacI transgene has been extensively used as a reporter Table  S1 . Error bars represent standard errors. Table  S2 and Table S3 . Error bars represent 95% confidence intervals.
of mutation events, and its effectiveness for this purpose was validated in numerous studies shortly after its initial introduction (20) (21) (22) (23) (24) (25) . As a result, it continues to be used extensively as a means to detect mutagenic events in vivo (26) (27) (28) (29) (30) .
The lacI transgene affords several advantages as a mutation reporter system. It remains unexpressed and hypermethylated (18) in all tissues examined, and this facilitates a uniform analysis of the relative frequency of mutational events in different tissues or in different individuals subjected to different circumstances (e.g., reproduction by natural conception or cloning). In addition, spectra and frequencies of mutations in the lacI transgene have been directly compared to those in endogenous mouse genes including hprt and Dlb1, and were found to be similar for all types of mutations other than large deletions or insertions, which are not well detected by the lacI transgene system due to packaging constraints of the lambda system, and were not the focus of our analysis (31) (32) (33) . Indeed, the extensive previous use of this system to determine the frequency and spectrum of point mutations in a wide variety of circumstances has rendered this the single best characterized target gene with regard to mutagenesis (24) . Furthermore, the detection of mutations in the lacI transgene affords other key advantages over methods designed to analyze mutational events at individual endogenous loci, including the lack of a requirement for selection in cell culture, and the ability to analyze any tissue at any stage. For these reasons, we felt this approach afforded us the optimal opportunity to accurately examine the frequency and spectrum of point mutations in cloned fetuses as compared to those in naturally conceived fetuses.
The differences in frequencies of point mutations detected in different cell types by the lacI transgene-based assay both in previous studies (12, 13) and in our study ( Fig. 1 and Table S1) indicate that genetic integrity is differentially maintained in a tissue-specific manner. Because the DNA sequence of the lacI transgene was initially identical in all of these cell types, this difference must be based, at least in part, on epigenetic differences. Given that somatic cells typically harbor more spontaneously acquired point mutations than germ cells, we initially wondered if fetuses produced by cloning from donor somatic cells would inherit higher frequencies of these mutations than fetuses produced from germ cells by natural conception. The fact that we observed no significant differences in the frequency of point mutations in the lacI transgene recovered from fetuses cloned from three different donor somatic cell types, and that fetuses cloned from all three somatic donor cell types showed relatively low frequencies of spontaneous point mutations equivalent to that seen in naturally conceived fetuses, indicates that viable cloned embryos typically do not inherit more mutations than naturally conceived embryos when only a single locus is analyzed. This is very likely because mutations acquired spontaneously in any cell population are typically rare, and the likelihood is therefore extremely remote that such a mutation will be carried by any single donor nucleus selected at random for transfer into an enucleated oocyte for cloning. Indeed, this phenomenon appears to create a bottleneck effect that limits transmission of acquired mutations from one generation to the next (Fig. 3) . Interestingly, the same can be said of transmission of point mutations acquired spontaneously in the germ line of either parent to offspring produced by natural conception, given that the parent-offspring relationship is based on a single spermatozoon and a single ovum in each case.
Any inherited mutation will normally be propagated to all cells in a cloned fetus. The lacI transgene is present as a tandem array of 40 copies per genome in the transgenic mouse line used in these studies (17) . Therefore an inherited mutation in even a single copy of the lacI gene in the 40-copy tandem array would yield an initial mutation frequency of at least 2.5%, which is more than three orders of magnitude greater than the mutation frequencies of 0.00099-0.001.03% that we detected in the cloned fetuses in our study (Fig. 1, Table S1 ). This indicates that none of the cloned fetuses we analyzed were derived from donor nuclei harboring a mutation in the lacI transgene at the time of nuclear transfer, and confirms that the frequency of detectable mutations in the transgene must initially have been zero in each cloned embryo. Therefore we concluded that all of the mutations we detected in cloned fetuses at mid-gestation must have accumulated spontaneously during development of these fetuses following nuclear transfer. Thus, our finding that the frequency of mutations was 0.87 ϫ 10 Ϫ5 in midgestation fetuses produced by natural conception, and 0.99 ϫ 10 Ϫ5 to 1.03 ϫ 10 Ϫ5 in fetuses produced by SCNT, indicates that the rate of accumulation of spontaneous mutations was similar in naturally conceived and cloned fetuses, respectively, regardless of the donor cell type used for cloning.
Cell-type specific differences in frequencies of spontaneous point mutations can be ascribed to a variety of effects, including the age of the cell, the extent of exposure to potentially mutagenic effects, or the rate of proliferation of a particular cell lineage. These represent different phenotypic characteristics of cells that could explain the initial differences in frequencies of mutations that we observed in the three donor somatic cell types examined in our study. Thus, fetal brain cells showed the lowest frequency of mutations-presumably reflecting their young age and limited opportunity to accumulate spontaneous mutations. Between the two adult donor cell types, cumulus cells showed a lower mutation frequency than skin cells-probably due to the lower rate of proliferation in the former. However, these effects cannot explain all cell-type specific differences in frequencies of spontaneous mutations. For example, the frequency of spontaneous mutations in spermatogenic cells and spermatozoa has been shown to be 5-10 times lower than that in adult somatic cells (14) . This is despite the fact that these cell types all derive from the highly proliferative seminiferous epithelium in adult males.
This suggests that there are mechanisms in addition to age and cellular proliferation rate that regulate genetic integrity in a tissue-specific manner. We assume that tissue-specific differ- ences in activities of DNA repair genes represent an important additional mechanism by which genetic integrity is differentially regulated in different cell types. Indeed, previous studies have shown that certain DNA repair activities are up-regulated in spermatogenic cells compared to somatic cells (34) , and we suspect that this is a primary cause of the lower frequency of point mutations (i.e., enhanced genetic integrity) previously observed in male germ cells (14) . Tissue-specific differences in DNA repair activities could result from transcriptional or posttranscriptional regulation of DNA repair genes. An example of the latter was recently reported in which certain proteins involved in the base-excision repair pathway were shown to be more quickly degraded if not part of a repair complex bound to DNA (35) . However, to the extent that tissue-specific differences in transcription of DNA repair genes contribute to different levels of DNA repair activities, we would suggest that epigenetic programming of these genes is a primary regulator of genetic integrity in each cell type. In this regard, differences in levels of transcripts expressed from DNA repair genes have been previously noted in germ cells and somatic cells respectively (36, 37), and we assume that early embryonic cells are likely to express DNA repair genes at levels similar to those in germ cells.
Thus, it appears that epigenetic mechanisms regulate the differential maintenance of genetic integrity in different cell types. However, despite the difference in epigenetic regulation of genetic integrity in germ cells and somatic cells, we found that fetuses produced from somatic cells by cloning accumulated spontaneous mutations at a rate similar to that in fetuses produced from germ cells by natural conception. This indicates that the epigenetic mechanisms that normally regulate maintenance of genetic integrity less stringently in somatic cells undergo reprogramming in cloned embryos such that maintenance of genetic integrity is similar during development following either natural conception involving germ cells or cloning from somatic cells.
Given this evidence for epigenetic regulation of genetic integrity, and our observations that this appears to function most stringently in germ cells and early embryos, we suggest that there may be a relationship between pluripotency and enhanced maintenance of genetic integrity. Thus, these results could have direct relevance to the genetic integrity of stem cells derived either by therapeutic cloning from, or direct reprogramming of, somatic cells (38) (39) (40) .
Materials and Methods
Mice. ''Big Blue'' female mice (Stratagene) homozygous for the lacI transgene on a C57BL/6 background (17, 41) were mated to DBA/2 males (NCI) to generate B6D2F1 (''BBM-BDF1'') hybrid offspring. These matings provided control fetuses produced by natural conception, and mice from which donor somatic cells were recovered for use in the cloning process. All mice were housed and killed in accordance with institutional and federal guidelines. All procedures involving live animals were approved in advance by the Institutional Animal Care and Use Committee at the University of Hawaii.
Donor Cell Preparation.
Three different somatic cell types were collected from BBM-BDF1 hybrid offspring, fetal brain, adult cumulus, and adult skin. These were then used as sources of donor nuclei for the generation of cloned embryos by SCNT. Fetal brain cells were collected from 15.5 dpc fetuses as described (42) . Adult cumulus cells were obtained from females at 2-4 months of age as previously described (43) . Adult skin cells were prepared from abdominal skin. Males at 2-3 months of age were euthanized and the abdominal area freed of hair. The abdominal skin was removed and washed with 5 ml of Ca 2ϩ -Mg 2ϩ free PBS. The skin was minced into small pieces and incubated with 5 ml of 0.2% collagenase (Sigma c-6885 made with DMEM) for 30 min at 37°C pipetting up and down every 10 min. The pieces were washed twice with 10% FBS/DMEM with penicillin/streptomycin antibiotics. These pieces were plated on a tissue culture dish coated with 0.1% gelatin and cultured with 20% FBS/DMEM at 37°C for 4 days. After 4 days in culture, skin pieces were removed and growing skin cells were cultured for 7-10 additional days, until confluent, changing media every 2-4 days.
Nuclear Transfer and Oocyte Activation. BDF1 mice (which did not carry the Big Blue transgene) were used as oocyte donors. Adult female mice were induced to superovulate by consecutive injections of pregnant mare serum gonadotropin (PMAS; 5IU) and equine chorionic gonadotrophin (eCG; 5IU) 48 h apart. Thirteen to 15 h after hCG injection, cumulus-oocyte complexes were collected from oviducts and cumulus cells were enzymatically dispersed as described (43) . The Honolulu method was used to perform enucleation of oocytes and piezo-assisted injection of donor cell nuclei into oocytes (43, 44) . The inner diameters of the enucleation and injection pipettes were Ϸ10 and 6 m at their tips, respectively. Enucleated oocytes injected with donor cell nuclei (reconstructed oocytes) were kept in CZB medium (44) for 2 h before they were activated by treatment with Ca 2ϩ -free CZB medium containing 10 mM SrCl2 and 5 g/ml Ϫ1 cytochalasin B for 6 h. Sr activates reconstituted oocytes and cytochalasin B causes retention of all chromosomes of the donor cell by preventing the loss of chromosomes into the pseudopolar body during oocyte activation (44) . After activation, reconstructed oocytes were cultured in CZB medium for 3 days at 37°C.
Embryo Transfer. After 3 days of culture, embryos reaching the morula or blastocyst stages were transferred into the oviducts of pseudopregnant CD-1 surrogate females mated the previous night with vasectomized males of the same strain. The day of transfer was considered day 0.5 of pregnancy (0.5 dpc). Surrogate females were euthanized on day 10.5 of pregnancy to collect cloned fetuses. The efficiencies of development of cloned fetuses at each step are summarized in Table S4 .
Recovery of High Molecular Weight DNA. High molecular weight DNA was isolated from populations of the three different donor cell types and from 10.5 dpc cloned fetuses of normal size and morphology derived from each donor cell type as previously described (18) . Briefly, for each donor cell type, Ϸ2-4 million cells were used for each DNA isolation procedure. For cloned embryos, a single whole fetus at 10.5 dpc was processed for each DNA sample. Frozen cells or fetuses were resuspended in 50 l of ice-cold lysis buffer and transferred to a 2-ml Kontes dounce tissue homogenizer and carefully homogenized Ϸ5 times with each of two plungers, first with plunger ''B'' and then with plunger ''A.'' The homogenate was filtered through a 100 m Millipore filter fitted onto a 1.5-ml microcentrifuge tube. The tube was centrifuged at 13,200 rpm for 15 min at 4°C, the supernatant was removed, and the pellet was resuspended in digestion buffer containing RNace-it (Stratagene) and incubated at 50°C for 5 min. 20 l of proteinase K solution was then added and the sample was incubated for Ϸ1.5 h at 50°C. 50 l of 1x TE was then added to each sample followed by drop dialysis by using a 0.025-m Millipore dialysis membrane floating on 500 mL of 1x TE for 2 days at room temperature.
Analysis of Mutation Frequency and Spectrum.
The lacI gene was recovered from high-molecular-weight genomic DNA using Transpack in vitro packaging extracts from Stratagene according to the manufacturer's instructions. Packaged phage were mixed with E. coli SCS-8 cells (Stratagene), added to top agarose containing X-gal, and plated at Յ17,500 pfu per 25 ϫ 25 cm NZY agar assay tray. Following incubation at 37°C for 16 -18 h, trays were visually screened for blue mutant plaques. All putative mutant plaques were identified by their circular appearance and blue color, counted, cored and replated on fresh X-gal/NZY plates to confirm and purify phage displaying the lacI mutant phenotype. Cored blue plaques yielding Ͼ75% blue plaques upon replating were then sequenced. After adjustment for jackpot mutations (clonal expansion of an early mutation counted as a single mutation regardless of how many times it appears in a single sample), the final mutation frequency was determined by dividing the number of confirmed, independent mutant plaques by the total number of plaque forming units. Isolated mutant phage samples were sent to the CBR DNA Sequencing Facility, University of Victoria, Canada, for sequencing analysis as previously described (18) . The wild-type lacI gene sequence was compared to the lacI gene sequence in each mutant phage to confirm and identify each individual mutation. Mutations were categorized as transitions (pyrimidine-to-pyrimidine or purine-to-purine substitutions), transversions (pyrimidine-to-purine substutition or vice versa), or small insertions or deletions.
Statistical Analysis. The numbers of mutations were analyzed by a Poisson regression model with parameter estimates obtained by the method of maximum likelihood (45) . Statistical tests of differences used the likelihood ratio test. Mutation spectrum data were analyzed using a 2 test for independence. Because of the low expected frequencies, the exact PϪvalue was calculated. All computations were carried out using SAS (version 9.1; SAS Institute). P Յ 0.05 was considered statistically significant.
